Somatic genetic alterations typically occurring in ER-positive, human epidermal growth factor receptor 2 (HER2)-negative FBC are less common in MBC, such as TP53 and PIK3CA mutations and 16q loss13. Here, ERBB2 is linked to complete blood cell count.